Presentations
Thrombosis and Hemostasis (CiTH) 30 October - November 1, 2014, Berlin, Germany
|
Patients with Factor VII or Factor XI deficiency: do they need treatment prior to surgery? P. Bolton-Maggs, UK
|
 |
|
Hemophiliacare: Currentguidelinesandapplicationsof new factor concentrates K. Fischer, Netherlands
|
|
|
NOACS for the treatment of atrial fibrillation - advantages E. Lev, Israel
|
|
|
New Antiplatelet Agents - Advantages E. Lev, Israel
|
|
|
Antiphospholipid syndrome in children - should similar diagnostic criteria be applied? V. Pengo, Italy
|
|
|
Bleeding Associated with NOACs: Assesing the Risk and Management D. Varon, Israel
|
|
|
Should infants with perinatal thrombosis be screened for thrombophilia and treated by anticoagulants? S. Revel-Vilk, Israel
|
|
|
Should we screen children for coagulopathies prior to surgery? S. Revel-Vilk, Israel
|
|
|
New Antiplatelet Agents: Limitations A. Michelson, USA
|
|
|
New Oral Anticoagulants in Children: Should They Be Prescribed For Special (Off Label) Situation? No A. Michelson, USA
|
|
|
The role of thrombopoietics in ITP J. Bussel, USA
|
|
|
Hemostasis and liver disease P. Mannucci, Italy
|
|